Barry T. Mori
Director Financiero/CFO en InterX, Inc. .
Perfil
Barry T.
Mori is currently the Chief Financial Officer & Director at InterX, Inc. Previously, he worked as the Chief Financial Officer & Vice President at Perquest, Inc. Mori holds an MBA from the University of California, Los Angeles and an undergraduate degree from the University of California, Berkeley.
Cargos activos de Barry T. Mori
| Empresas | Cargo | Inicio |
|---|---|---|
InterX, Inc.
 InterX, Inc. Pharmaceuticals: MajorHealth Technology Part of NeoTX Therapeutics Ltd., InterX, Inc. develops cancer therapies. The company is based in Walnut Creek, CA. The company was founded by Roger David Kornberg, Boris Fain. The CEO is Paul Marinelli. InterX was acquired by NeoTX Therapeutics Ltd. on May 12, 2022. | Director Financiero/CFO | - |
Antiguos cargos conocidos de Barry T. Mori.
| Empresas | Cargo | Fin |
|---|---|---|
Perquest, Inc.
 Perquest, Inc. Miscellaneous Commercial ServicesCommercial Services Perquest, Inc. provides online payroll and employer services. The company was founded by David E. Kahn in 2001 and is headquartered in Dublin, CA. | Director Financiero/CFO | - |
Formación de Barry T. Mori.
| University of California, Los Angeles | Masters Business Admin |
| University of California, Berkeley | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Perquest, Inc.
Perquest, Inc. Miscellaneous Commercial ServicesCommercial Services Perquest, Inc. provides online payroll and employer services. The company was founded by David E. Kahn in 2001 and is headquartered in Dublin, CA. | Commercial Services |
InterX, Inc.
InterX, Inc. Pharmaceuticals: MajorHealth Technology Part of NeoTX Therapeutics Ltd., InterX, Inc. develops cancer therapies. The company is based in Walnut Creek, CA. The company was founded by Roger David Kornberg, Boris Fain. The CEO is Paul Marinelli. InterX was acquired by NeoTX Therapeutics Ltd. on May 12, 2022. | Health Technology |
- Bolsa de valores
- Insiders
- Barry T. Mori
